Company: VCYT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001384101-25-000014
Chunk: 158

Company: VERACYTE, INC.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 158
---
 at December 31, 202171,123 $71 $1,468,683 $(357,157)$(15,083)$1,096,514 Issuance of common stock on exercise of stock options and vesting of restricted stock units681 1 4,193 — — 4,194 Issuance of common stock under employee stock purchase plan (ESPP)155 — 3,748 — — 3,748 Tax portion of vested restricted stock units— — (3,167)— — (3,167)Stock-based compensation expense (employee)— — 24,781 — — 24,781 Stock-based compensation expense (non-employee)— — 11 — — 11 Stock-based compensation expense (ESPP)— — 1,942 — — 1,942 Net loss— — — (36,560)— (36,560)Comprehensive loss— — — — (16,263)(16,263)Balance at December 31, 202271,959 72 1,500,191 (393,717)(31,346)1,075,200 Issuance of common stock on exercise of stock options and vesting of restricted stock units1,160 1 6,424 — — 6,425 Issuance of common stock under ESPP146 — 3,153 — — 3,153 Tax portion of vested restricted stock units— — (6,741)— — (6,741)Stock-based compensation expense (employee)— — 31,494 — — 31,494 Stock-based compensation expense (ESPP)— — 1,647 — — 1,647 Net loss— — — (74,404)— (74,404)Comprehensive income— — — — 7,328 7,328 Balance at December 31, 202373,265 73 1,536,168 (468,121)(24,018)1,044,102 Issuance of common stock and options for acquisition2,698 3 74,142 — — 74,145 Issuance of common stock on exercise of stock options and vesting of restricted